BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 21449912)

  • 1. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.
    Youssef J; Badr M
    Br J Pharmacol; 2011 Sep; 164(1):68-82. PubMed ID: 21449912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention.
    Peters JM; Shah YM; Gonzalez FJ
    Nat Rev Cancer; 2012 Feb; 12(3):181-95. PubMed ID: 22318237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of PPARs in Disease.
    Wagner N; Wagner KD
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs and Myocardial Infarction.
    Wagner KD; Wagner N
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors.
    Murakami I; Wakasa Y; Yamashita S; Kurihara T; Zama K; Kobayashi N; Mizutani Y; Mitsutake S; Shigyo T; Igarashi Y
    Lipids Health Dis; 2011 Aug; 10():150. PubMed ID: 21861924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.
    Genini D; Catapano CV
    J Recept Signal Transduct Res; 2006; 26(5-6):679-92. PubMed ID: 17118805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three peroxisome proliferator-activated receptor isotypes from each of two species of marine fish.
    Leaver MJ; Boukouvala E; Antonopoulou E; Diez A; Favre-Krey L; Ezaz MT; Bautista JM; Tocher DR; Krey G
    Endocrinology; 2005 Jul; 146(7):3150-62. PubMed ID: 15790725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARs and Angiogenesis-Implications in Pathology.
    Wagner N; Wagner KD
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR expression throughout the oestrous cycle in the bovine endometrium.
    Socha BM; Łupicka M; Szczepańska AA; Korzekwa AJ
    Theriogenology; 2017 Sep; 100():88-94. PubMed ID: 28708539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer.
    Psilopatis I; Vrettou K; Troungos C; Theocharis S
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.
    Sertznig P; Seifert M; Tilgen W; Reichrath J
    J Cell Physiol; 2007 Jul; 212(1):1-12. PubMed ID: 17443682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A; Wahli W
    Swiss Med Wkly; 2010; 140():w13071. PubMed ID: 20842602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?
    Gupta M; Mahajan VK; Mehta KS; Chauhan PS; Rawat R
    Arch Dermatol Res; 2015 Nov; 307(9):767-80. PubMed ID: 25986745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A; Benedetti E; Cristiano L; Sebastiani P; D'Amico MA; D'Angelo B; Di Loreto S
    Neuroscience; 2005; 130(2):325-37. PubMed ID: 15664689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
    Cheang WS; Tian XY; Wong WT; Huang Y
    Br J Pharmacol; 2015 Dec; 172(23):5512-22. PubMed ID: 25438608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.